Skip to main content
SpringerLink
Log in

Peoniflorin Preconditioning Protects Against Myocardial Ischemia/Reperfusion Injury Through Inhibiting Myocardial Apoptosis: RISK Pathway Involved

  • Original Article
  • Published:
Applied Biochemistry and Biotechnology Aims and scope Submit manuscript

Abstract

Preconditioning with Peoniflorin, a component of traditional Chinese prescriptions, was proposed to be a potential strategy for cardioprotection against ischemia/reperfusion (I/R) injury. However, the cardioprotective effect of Peoniflorin preconditioning has not been thoroughly confirmed, and the underlying mechanism remains unclear. Here, we examined the cardioprotective effect and its mechanism of Peoniflorin preconditioning against myocardial I/R injury. Rats were subjected to 30 min of transient ischemia followed by 2 h of reperfusion with or without Peoniflorin (100 mg/kg) prior to reperfusion. Peoniflorin preconditioning significantly limited myocardial infarct size and reperfusion arrhythmias, as well as obviously attenuated the histomorphological and micromorphological damages induced by I/R injury. The reduced myocardial injury was also associated with the anti-apoptotic effect of Peoniflorin, as evidence by decreased TUNEL-positive cells, upregulation of BCL-2 expression, and downregulation of Bax and caspase-3 expression. In an effort to evaluate the mechanism responsible for the observed cardioprotective and anti-apoptotic effect, Western blot of phosphorylated protein was performed after 20 min of reperfusion. Results showed that Peoniflorin preconditioning activated both the Akt and ERK1/2 arm of the reperfusion injury salvage kinase (RISK) pathway. To further confirm this mechanism, the PI3K signaling inhibitor LY294002 and ERK1/2 signaling inhibitor PD98059 were administered in vivo. The cardioprotective and anti-apoptotic effects of Peoniflorin preconditioning were diminished but not abolished by pretreatment with LY294002 or PD98059. Taken together, these results indicate that Peoniflorin preconditioning protects the myocardial against I/R injury and inhibits myocardial apoptosis via the activation of the RISK pathway, highlighting the potential therapeutic effects of Peoniflorin on reducing myocardial I/R injury.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8

Similar content being viewed by others

Data Availability

Not applicable

References

  1. Hillis, L. D., & Lange, R. A. (2006). Myocardial infarction and the open-artery hypothesis. New England Journal of Medicine, 355, 2475–2477. https://doi.org/10.1056/NEJMe068251

    Article  CAS  Google Scholar 

  2. Rodriguez-Sinovas, A., Abdallah, Y., Piper, H. M., & Garcia-Dorado, D. (2007). Reperfusion injury as a therapeutic challenge in patients with acute myocardial infarction. Heart Failure Reviews, 12, 207–216. https://doi.org/10.1007/s10741-007-9039-9

    Article  CAS  PubMed  Google Scholar 

  3. Hausenloy, D. J., & Yellon, D. M. (2007). Preconditioning and postconditioning: United at reperfusion. Pharmacology and Therapeutics, 116, 173–191. S0163-7258(07)00125-8.

    Article  CAS  Google Scholar 

  4. Staat, P., Rioufol, G., Piot, C., Cottin, Y., Cung, T. T., L’Huillier, I., Aupetit, J. F., Bonnefoy, E., Finet, G., Andre-Fouet, X., & Ovize, M. (2005). Postconditioning the human heart. Circulation, 112, 2143–2148. CIRCULATIONAHA.105.558122.

    Article  Google Scholar 

  5. Heusch, G., Botker, H. E., Przyklenk, K., Redington, A., & Yellon, D. (2015). Remote ischemic conditioning. Journal of the American College of Cardiology, 65, 177–195. https://doi.org/10.1016/j.jacc.2014.10.031

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Hahn, J. Y., Song, Y. B., Kim, E. K., Yu, C. W., Bae, J. W., Chung, W. Y., Choi, S. H., Choi, J. H., Bae, J. H., An, K. J., Park, J. S., Oh, J. H., Kim, S. W., Hwang, J. Y., Ryu, J. K., Park, H. S., Lim, D. S., & Gwon, H. C. (2013). Ischemic postconditioning during primary percutaneous coronary intervention: The effects of postconditioning on myocardial reperfusion in patients with ST-segment elevation myocardial infarction (POST) randomized trial. Circulation, 128, 1889–1896. https://doi.org/10.1161/CIRCULATIONAHA.113.001690

    Article  CAS  PubMed  Google Scholar 

  7. Ibanez, B., Heusch, G., Ovize, M., & Van de Werf, F. (2015). Evolving therapies for myocardial ischemia/reperfusion injury. Journal of the American College of Cardiology, 65, 1454–1471. S0735-1097(15)00669-5.

    Article  Google Scholar 

  8. Fernandez-Jimenez, R., & Ibanez, B. (2015). CAESAR: One step beyond in the construction of a translational bridge for cardioprotection. Circulation Research, 116, 554–556. https://doi.org/10.1161/CIRCRESAHA.115.305841

    Article  CAS  PubMed  Google Scholar 

  9. Garcia-Dorado, D., Garcia-del-Blanco, B., Otaegui, I., Rodriguez-Palomares, J., Pineda, V., Gimeno, F., Ruiz-Salmeron, R., Elizaga, J., Evangelista, A., Fernandez-Aviles, F., San-Roman, A., & Ferreira-Gonzalez, I. (2014). Intracoronary injection of adenosine before reperfusion in patients with ST-segment elevation myocardial infarction: A randomized controlled clinical trial. International Journal of Cardiology, 177, 935–941. https://doi.org/10.1016/j.ijcard.2014.09.203

    Article  PubMed  Google Scholar 

  10. Jones, S. P., Tang, X. L., Guo, Y., Steenbergen, C., Lefer, D. J., Kukreja, R. C., Kong, M., Li, Q., Bhushan, S., Zhu, X., Du, J., Nong, Y., Stowers, H. L., Kondo, K., Hunt, G. N., Goodchild, T. T., Orr, A., Chang, C. C., Ockaili, R., … Bolli, R. (2015). The NHLBI-sponsored Consortium for preclinicAl assESsment of cARdioprotective therapies (CAESAR): A new paradigm for rigorous, accurate, and reproducible evaluation of putative infarct-sparing interventions in mice, rabbits, and pigs. Circulation Research, 116, 572–586. https://doi.org/10.1161/CIRCRESAHA.116.305462

    Article  CAS  PubMed  Google Scholar 

  11. Chou, T. C. (2003). Anti-inflammatory and analgesic effects of paeonol in carrageenan-evoked thermal hyperalgesia. British Journal of Pharmacology, 139, 1146–1152. https://doi.org/10.1038/sj.bjp.0705360

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Ye, J., Duan, H., Yang, X., Yan, W., & Zheng, X. (2001). Anti-thrombosis effect of paeoniflorin: Evaluated in a photochemical reaction thrombosis model in vivo. Planta Medica, 67, 766–767. https://doi.org/10.1055/s-2001-18364

    Article  CAS  PubMed  Google Scholar 

  13. Qian, G. Q., Ding, J., Zhang, X., Yin, X., Gao, Y., & Zhao, G. P. (2015). Preconditioning with glycyrrhizic, ferulic, paeoniflorin, cinnamic prevents rat hearts from ischemia/reperfusion injury via endothelial nitric oxide pathway. Pharmacognosy Magazine, 11, 292–296. https://doi.org/10.4103/0973-1296.153081

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Hsieh, C. L., Cheng, C. Y., Tsai, T. H., Lin, I. H., Liu, C. H., Chiang, S. Y., Lin, J. G., Lao, C. J., & Tang, N. Y. (2006). Paeonol reduced cerebral infarction involving the superoxide anion and microglia activation in ischemia-reperfusion injured rats. Journal of Ethnopharmacology, 106, 208–215. S0378-8741(05)00846-9.

    Article  CAS  Google Scholar 

  15. Chen, Y. F., Wu, K. J., & Wood, W. G. (2013). Paeonia lactiflora extract attenuating cerebral ischemia and arterial intimal hyperplasia is mediated by paeoniflorin via modulation of VSMC migration and Ras/MEK/ERK signaling pathway. Evidence-based Complementary and Alternative Medicine, 2013, 482428. https://doi.org/10.1155/2013/482428

    Article  PubMed  PubMed Central  Google Scholar 

  16. Guo, R. B., Wang, G. F., Zhao, A. P., Gu, J., Sun, X. L., & Hu, G. (2012). Paeoniflorin protects against ischemia-induced brain damages in rats via inhibiting MAPKs/NF-kappaB-mediated inflammatory responses. PLoS One, 7, e49701. https://doi.org/10.1371/journal.pone.0049701

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Nizamutdinova, I. T., Jin, Y. C., Kim, J. S., Yean, M. H., Kang, S. S., Kim, Y. S., Lee, J. H., Seo, H. G., Kim, H. J., & Chang, K. C. (2008). Paeonol and paeoniflorin, the main active principles of Paeonia albiflora, protect the heart from myocardial ischemia/reperfusion injury in rats. Planta Medica, 74, 14–18. https://doi.org/10.1055/s-2007-993775

    Article  CAS  PubMed  Google Scholar 

  18. Qian, G. Q., Peng, X., Cai, C., & Zhao, G. P. (2014). Effect on eNOS/NO pathway in MIRI rats with preconditioning of GFPC from Dang Gui Si Ni decoction. Pharmacognosy Research, 6, 133–137. https://doi.org/10.4103/0974-8490.129032

    Article  PubMed  PubMed Central  Google Scholar 

  19. Hausenloy, D. J., & Yellon, D. M. (2007). Reperfusion injury salvage kinase signalling: Taking a RISK for cardioprotection. Heart Failure Reviews, 12, 217–234. https://doi.org/10.1007/s10741-007-9026-1

    Article  CAS  PubMed  Google Scholar 

  20. Badalzadeh, R., Mokhtari, B., & Yavari, R. (2015). Contribution of apoptosis in myocardial reperfusion injury and loss of cardioprotection in diabetes mellitus. The Journal of Physiological Sciences, 65, 201–215. https://doi.org/10.1007/s12576-015-0365-8

    Article  PubMed  Google Scholar 

  21. Weinreuter, M., Kreusser, M. M., Beckendorf, J., Schreiter, F. C., Leuschner, F., Lehmann, L. H., Hofmann, K. P., Rostosky, J. S., Diemert, N., Xu, C., Volz, H. C., Jungmann, A., Nickel, A., Sticht, C., Gretz, N., Maack, C., Schneider, M. D., Grone, H. J., Muller, O. J., … Backs, J. (2014). CaM kinase II mediates maladaptive post-infarct remodeling and pro-inflammatory chemoattractant signaling but not acute myocardial ischemia/reperfusion injury. EMBO Molecular Medicine, 6, 1231–1245. https://doi.org/10.15252/emmm.201403848

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Walker, M. J., Curtis, M. J., Hearse, D. J., Campbell, R. W., Janse, M. J., Yellon, D. M., Cobbe, S. M., Coker, S. J., Harness, J. B., Harron, D. W., et al. (1988). The Lambeth Conventions: Guidelines for the study of arrhythmias in ischaemia infarction, and reperfusion. Cardiovascular Research, 22, 447–455.

    Article  CAS  Google Scholar 

  23. Curtis, M. J. (1998). Characterisation, utilisation and clinical relevance of isolated perfused heart models of ischaemia-induced ventricular fibrillation. Cardiovascular Research, 39, 194–215.

    Article  CAS  Google Scholar 

  24. Ghaboura, N., Tamareille, S., Ducluzeau, P. H., Grimaud, L., Loufrani, L., Croue, A., Tourmen, Y., Henrion, D., Furber, A., & Prunier, F. (2011). Diabetes mellitus abrogates erythropoietin-induced cardioprotection against ischemic-reperfusion injury by alteration of the RISK/GSK-3beta signaling. Basic Research in Cardiology, 106, 147–162. https://doi.org/10.1007/s00395-010-0130-3

    Article  CAS  PubMed  Google Scholar 

  25. Orogo, A. M., & Gustafsson, A. B. (2013). Cell death in the myocardium: My heart won’t go on. IUBMB Life, 65, 651–656. https://doi.org/10.1002/iub.1180

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Kloner, R. A., Ellis, S. G., Lange, R., & Braunwald, E. (1983). Studies of experimental coronary artery reperfusion. Effects on infarct size, myocardial function, biochemistry, ultrastructure and microvascular damage. Circulation, 68, I8-15.

    CAS  PubMed  Google Scholar 

  27. Ma, L. L., Zhang, F. J., Qian, L. B., Kong, F. J., Sun, J. F., Zhou, C., Peng, Y. N., Xu, H. J., Wang, W. N., Wen, C. Y., Zhu, M. H., Chen, G., Yu, L. N., Liu, X. B., Wang, J. A., & Yan, M. (2013). Hypercholesterolemia blocked sevoflurane-induced cardioprotection against ischemia-reperfusion injury by alteration of the MG53/RISK/GSK3beta signaling. International Journal of Cardiology, 168, 3671–3678. https://doi.org/10.1016/j.ijcard.2013.06.037

    Article  PubMed  Google Scholar 

  28. Penna, C., Settanni, F., Tullio, F., Trovato, L., Pagliaro, P., Alloatti, G., Ghigo, E., & Granata, R. (2013). GH-releasing hormone induces cardioprotection in isolated male rat heart via activation of RISK and SAFE pathways. Endocrinology, 154, 1624–1635. https://doi.org/10.1210/en.2012-2064

    Article  CAS  PubMed  Google Scholar 

  29. Somers, S. J., Frias, M., Lacerda, L., Opie, L. H., & Lecour, S. (2012). Interplay between SAFE and RISK pathways in sphingosine-1-phosphate-induced cardioprotection. Cardiovascular Drugs and Therapy, 26, 227–237. https://doi.org/10.1007/s10557-012-6376-2

    Article  CAS  PubMed  Google Scholar 

  30. Garcia-Prieto, J., Garcia-Ruiz, J. M., Sanz-Rosa, D., Pun, A., Garcia-Alvarez, A., Davidson, S. M., Fernandez-Friera, L., Nuno-Ayala, M., Fernandez-Jimenez, R., Bernal, J. A., Izquierdo-Garcia, J. L., Jimenez-Borreguero, J., Pizarro, G., Ruiz-Cabello, J., Macaya, C., Fuster, V., Yellon, D. M., & Ibanez, B. (2014). Beta3 adrenergic receptor selective stimulation during ischemia/reperfusion improves cardiac function in translational models through inhibition of mPTP opening in cardiomyocytes. Basic Research in Cardiology, 109, 422. https://doi.org/10.1007/s00395-014-0422-0

    Article  CAS  PubMed  Google Scholar 

  31. Meng, X. B., Sun, G. B., Wang, M., Sun, J., Qin, M., & Sun, X. B. (2013). P90RSK and Nrf2 activation via MEK1/2-ERK1/2 pathways mediated by notoginsenoside R2 to prevent 6-hydroxydopamine-induced apoptotic death in SH-SY5Y Cells. Evidence-based Complementary and Alternative Medicine, 2013, 971712. https://doi.org/10.1155/2013/971712

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Funding

This study was supported by grants from the National Natural Science Foundation of China (No. 81673787), the Natural Science Foundation of Shaanxi (No. 2014JM2-8160), and the Medical Research Project of Xi’an Technology and Social Development Guiding Plan (No. SF1416).

Author information

Author notes

  1. Hongen Ma and Jiping Hao contributed equally to this work and should be considered as co-first authors

Authors and Affiliations

  1. Department of Cardiology, Ninth Affiliated Hospital of Medical College of Xi’an Jiaotong University, No. 151 East Section of South Second Ring RoadBeilin District, Xi’an, 710054, Shaanxi, China

    Hongen Ma, Jiping Hao, Meilin Liu, Shaohui He & Yuqin Gao

  2. Medical College of Yan’an University, No. 38 Guanghua RoadBaota District, Yan’an, 716000, Shaanxi, China

    Huihui Liu, Jia Yin & Mingmin Qiang

  3. Department of Cardiology, Tangdu Hospital, Fourth Military Medical University, No. 1 Xinsi RoadBaqiao District, Xi’an, 710000, Shaanxi, China

    Di Zeng, Xiongtao Liu & Cheng Lian

Authors
  1. Hongen Ma
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jiping Hao
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Huihui Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Jia Yin
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Mingmin Qiang
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Meilin Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Shaohui He
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Di Zeng
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Xiongtao Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Cheng Lian
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Yuqin Gao
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

The authors contributed equally.

Corresponding author

Correspondence to Yuqin Gao.

Ethics declarations

Ethics Approval

Not applicable

Consent to Participate

All authors have their consent to participate.

Consent for Publication

All authors have their consent to publish their work.

Competing Interests

The authors declare no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 296 KB)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ma, H., Hao, J., Liu, H. et al. Peoniflorin Preconditioning Protects Against Myocardial Ischemia/Reperfusion Injury Through Inhibiting Myocardial Apoptosis: RISK Pathway Involved. Appl Biochem Biotechnol 194, 1149–1165 (2022). https://doi.org/10.1007/s12010-021-03680-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12010-021-03680-z

Keywords

Search

Navigation